The PERSPECTIVE trial examined procedural, clinical and health status outcomes using contemporary methods and was reviewed by an independent core laboratory and events committee. Among consecutive patients undergoing attempted CTO PCI, procedural and in-hospital clinical outcomes were examined in addition to...
Traditionally, clinical treatment strategies have been approved based on average-population-benefit decisions derived from the randomized clinical trials of unselected patients, which were the cornerstone of traditional drug approvals. Tissue-of-origin trials are drug-centered, which refers to investigations...
According to Pulmonary Hypertension News, "These agents target cell signaling pathways known to play a role in PAH, which include the prostacyclin pathway, the endothelin pathway, and the nitric oxide pathway. All were shown to increase patient survival during clinical t...
Information resource for gene therapy news, clinical trials, guidelines, regulation, literature, databases, background and educational information, scientific r
Two studies into deadly cancers in dogs are now underway, offered through the newly formed Clinical Trials Office at Cummings Veterinary Medical Center at Tufts University. Dogs with spontaneous osteosarcoma, as well as dogs with mast cell tumors and sol
Among the clinical trials newly registered in the last 4 years, four articles pertaining to two trials have been published in peer-reviewed scientific journals. The characteristics of the published randomized controlled trials are summarized in Table7[43,53,83,84]. Two articles reported the results...
April 16, 2024 By Jordyn Sava News Article Three additional clinical trials will study nadofaragene firadenovec-vncg for the treatment of patients with non-muscle invasive bladder cancer. Bladder Cancer, Urinary Bladder Image: © reineg - stock.adobe.com Three new nadofaragene firadenovec-...
In 2021, China’s drug clinical trials were still dominated by chemical drugs, accounting for 70.8%. This was followed by biological products at 26.7%. The least was Chinese medicine, only 2.4%. Compared with the data of the past three years, the proportion of clinical trials of various dru...
This release contains forward-looking statements, including the market demand for and acceptance of Veeva’s products and services, the results from use of Veeva’s products and services, and general business conditions, particularly in the life sciences industry. Any forward-looking statements containe...
Eisai presents full results of lecanemab Phase 3 confirmatory Clarity AD study for early Alzheimer's disease at Clinical Trials on Alzheimer's Disease (CTAD) conference. Available at:https://www.eisai.co.jp/news/2022/news202285.html van Dyck. C, et al. Lecanemab in Early Alzheimer's Dise...